{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T04:01:56Z","timestamp":1746936116289,"version":"3.40.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12010-024-05162-4","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T09:45:22Z","timestamp":1737020722000},"page":"3008-3025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circ-NMNAT1 Drives Tumor Progression in Bladder Cancer by Modulating the miR-370-3p\/ATXN2L Axis"],"prefix":"10.1007","volume":"197","author":[{"given":"ChenHui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LiJuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ChangQing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1708-2390","authenticated-orcid":false,"given":"ZhaoGuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"1","key":"5162_CR1","first-page":"7","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68(1), 7\u201330.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"5162_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40880-015-0001-2","volume":"27","author":"W Chen","year":"2015","unstructured":"Chen, W., Zheng, R., Zeng, H., Zhang, S., & He, J. (2015). Annual report on status of cancer in China, 2011. Chinese Journal of Cancer Research, 27(1), 2\u201312.","journal-title":"Chinese Journal of Cancer Research"},{"key":"5162_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-pathol-012513-104703","volume":"11","author":"B Czerniak","year":"2016","unstructured":"Czerniak, B., Dinney, C., & McConkey, D. (2016). Origins of bladder cancer. Annual Review of Pathology: Mechanisms of Disease, 11, 149\u2013174.","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"issue":"1","key":"5162_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.56434\/j.arch.esp.urol.20237601.7","volume":"76","author":"X Zhang","year":"2023","unstructured":"Zhang, X., Liu, H., Zhang, J., Wang, Z., Yang, S., Liu, D., et al. (2023). Fibronectin-1: A predictive immunotherapy response biomarker for muscle-invasive bladder cancer. Archivos Espanoles de Urologia, 76(1), 70\u201383.","journal-title":"Archivos Espanoles de Urologia"},{"issue":"3","key":"5162_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccell.2017.07.001","volume":"32","author":"B Strilic","year":"2017","unstructured":"Strilic, B., & Offermanns, S. (2017). Intravascular survival and extravasation of tumor cells. Cancer Cell, 32(3), 282\u2013293.","journal-title":"Cancer Cell"},{"issue":"3","key":"5162_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen, L. S., Jakobsen, T., Hager, H., & Kjems, J. (2022). The emerging roles of circRNAs in cancer and oncology. Nature Reviews. Clinical Oncology, 19(3), 188\u2013206.","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"6","key":"5162_CR7","first-page":"1571","volume":"10","author":"D Wang","year":"2018","unstructured":"Wang, D., Yang, S., Wang, H., Wang, J., Zhang, Q., Zhou, S., et al. (2018). The progress of circular RNAs in various tumors. Am J Transl Res., 10(6), 1571\u20131582.","journal-title":"Am J Transl Res."},{"issue":"4","key":"5162_CR8","first-page":"3463","volume":"20","author":"W Zhao","year":"2019","unstructured":"Zhao, W., Dong, M., Pan, J., Wang, Y., Zhou, J., Ma, J., et al. (2019). Circular RNAs: A novel target among non-coding RNAs with potential roles in malignant tumors (review). Molecular Medicine Reports, 20(4), 3463\u20133474.","journal-title":"Molecular Medicine Reports"},{"issue":"5","key":"5162_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.11946","volume":"23","author":"L Yang","year":"2021","unstructured":"Yang, L., Zou, X., Zou, J., & Zhang, G. (2021). Functions of circular RNAs in bladder, prostate and renal cell cancer (Review). Mol Med Rep, 23(5), 1.","journal-title":"Mol Med Rep"},{"issue":"1","key":"5162_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-019-0800-z","volume":"12","author":"W Huang","year":"2019","unstructured":"Huang, W., Fang, K., Chen, T. Q., Zeng, Z. C., Sun, Y. M., Han, C., et al. (2019). circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression. Journal of Hematology & Oncology, 12(1), 103.","journal-title":"Journal of Hematology & Oncology"},{"issue":"8","key":"5162_CR11","doi-asserted-by":"publisher","first-page":"14296","DOI":"10.1002\/jcp.28128","volume":"234","author":"T Song","year":"2019","unstructured":"Song, T., Xu, A., Zhang, Z., Gao, F., Zhao, L., Chen, X., et al. (2019). CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075. Journal of Cellular Physiology, 234(8), 14296\u201314305.","journal-title":"Journal of Cellular Physiology"},{"issue":"7","key":"5162_CR12","doi-asserted-by":"publisher","first-page":"10080","DOI":"10.1002\/jcp.27941","volume":"234","author":"R Abdollahzadeh","year":"2019","unstructured":"Abdollahzadeh, R., Daraei, A., Mansoori, Y., Sepahvand, M., Amoli, M. M., & Tavakkoly-Bazzaz, J. (2019). Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer. Journal of Cellular Physiology, 234(7), 10080\u201310100.","journal-title":"Journal of Cellular Physiology"},{"issue":"3","key":"5162_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4149\/neo_2023_220904N894","volume":"70","author":"XL Xue","year":"2023","unstructured":"Xue, X. L., Zhao, S., Xu, M. C., Li, Y., Liu, W. F., & Qin, H. Z. (2023). Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p\/YAP1 axis. Neoplasma, 70(3), 430\u2013442.","journal-title":"Neoplasma"},{"key":"5162_CR14","doi-asserted-by":"publisher","first-page":"704683","DOI":"10.3389\/fcell.2021.704683","volume":"9","author":"F Wang","year":"2021","unstructured":"Wang, F., Zhang, Y., Zhou, X., Chen, X., Xiang, J., Fan, M., et al. (2021). Circular RNA CircPPP1CB suppresses tumorigenesis by interacting with the MiR-1307-3p\/SMG1 axis in human bladder cancer. Front Cell Dev Biol, 9, 704683.","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"5162_CR15","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.3390\/ijms25126384","volume":"25","author":"K Hasegawa","year":"2024","unstructured":"Hasegawa, K., Tamaki, M., Sakamaki, Y., & Wakino, S. (2024). Nmnat1 deficiency causes mitoribosome excess in diabetic nephropathy mediated by transcriptional repressor HIC1. Int J Mol Sci., 25(12), 6384.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"5162_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-022-01312-5","volume":"15","author":"W Zhang","year":"2022","unstructured":"Zhang, W., He, X., Yin, H., Cao, W., Lin, T., Chen, W., et al. (2022). Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis. Journal of Hematology & Oncology, 15(1), 93.","journal-title":"Journal of Hematology & Oncology"},{"issue":"5","key":"5162_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson, D. W., & Dinger, M. E. (2016). Endogenous microRNA sponges: Evidence and controversy. Nature Reviews Genetics, 17(5), 272\u2013283.","journal-title":"Nature Reviews Genetics"},{"issue":"8","key":"5162_CR18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1158\/0008-5472.CAN-16-2609","volume":"77","author":"JGM van Kampen","year":"2017","unstructured":"van Kampen, J. G. M., van Hooij, O., Jansen, C. F., Smit, F. P., van Noort, P. I., Schultz, I., et al. (2017). miRNA-520f reverses epithelial-to-mesenchymal transition by targeting ADAM9 and TGFBR2. Cancer Research, 77(8), 2008\u20132017.","journal-title":"Cancer Research"},{"issue":"11","key":"5162_CR19","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1158\/0008-5472.CAN-08-4043","volume":"69","author":"L Dyrskj\u00f8t","year":"2009","unstructured":"Dyrskj\u00f8t, L., Ostenfeld, M. S., Bramsen, J. B., Silahtaroglu, A. N., Lamy, P., Ramanathan, R., et al. (2009). Genomic profiling of microRNAs in bladder cancer: MiR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Research, 69(11), 4851\u20134860.","journal-title":"Cancer Research"},{"issue":"18","key":"5162_CR20","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1074\/jbc.RA118.001689","volume":"293","author":"X Huang","year":"2018","unstructured":"Huang, X., Zhu, H., Gao, Z., Li, J., Zhuang, J., Dong, Y., et al. (2018). Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p. Journal of Biological Chemistry, 293(18), 6693\u20136706.","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"5162_CR21","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1007\/s13277-015-4571-z","volume":"37","author":"C Wang","year":"2016","unstructured":"Wang, C., Ge, Q., Chen, Z., Hu, J., Li, F., & Ye, Z. (2016). Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1\/WAF1) expression. Tumour Biology, 37(5), 6589\u20136598.","journal-title":"Tumour Biology"},{"key":"5162_CR22","doi-asserted-by":"publisher","first-page":"30941","DOI":"10.1038\/srep30941","volume":"6","author":"K Yamane","year":"2016","unstructured":"Yamane, K., Naito, H., Wakabayashi, T., Yoshida, H., Muramatsu, F., Iba, T., et al. (2016). Regulation of SLD5 gene expression by miR-370 during acute growth of cancer cells. Science and Reports, 6, 30941.","journal-title":"Science and Reports"},{"key":"5162_CR23","doi-asserted-by":"crossref","unstructured":"Scheunemann D, Pradhan AK, Das SK, Sarkar D, Emdad L, Fisher PB. Wnt7a and miR-370\u20133p: new contributors to bladder cancer invasion. Biotarget. 2018;2.","DOI":"10.21037\/biotarget.2018.08.02"},{"issue":"61","key":"5162_CR24","doi-asserted-by":"publisher","first-page":"103775","DOI":"10.18632\/oncotarget.21790","volume":"8","author":"I Panagopoulos","year":"2017","unstructured":"Panagopoulos, I., Gorunova, L., Spetalen, S., Bassarova, A., Beiske, K., Micci, F., et al. (2017). Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma. Oncotarget, 8(61), 103775\u2013103784.","journal-title":"Oncotarget"},{"issue":"10","key":"5162_CR25","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.cellsig.2008.05.018","volume":"20","author":"D Nonis","year":"2008","unstructured":"Nonis, D., Schmidt, M. H. H., van de Loo, S., Eich, F., Dikic, I., Nowock, J., et al. (2008). Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cellular Signalling, 20(10), 1725\u20131739.","journal-title":"Cellular Signalling"},{"issue":"3","key":"5162_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41419-019-1362-2","volume":"10","author":"L Lin","year":"2019","unstructured":"Lin, L., Li, X., Pan, C., Lin, W., Shao, R., Liu, Y., et al. (2019). ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance. Cell Death & Disease, 10(3), 173.","journal-title":"Cell Death & Disease"},{"issue":"8","key":"5162_CR27","doi-asserted-by":"publisher","first-page":"11969","DOI":"10.18632\/aging.202900","volume":"13","author":"X Wang","year":"2021","unstructured":"Wang, X., Sheng, W., Xu, T., Xu, J., Gao, R., & Zhang, Z. (2021). CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p\/PPAR\u03b1\/CCL2 pathway. Aging (Albany NY)., 13(8), 11969\u201311987.","journal-title":"Aging (Albany NY)."},{"issue":"1","key":"5162_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-018-0771-7","volume":"17","author":"C Yang","year":"2018","unstructured":"Yang, C., Yuan, W., Yang, X., Li, P., Wang, J., Han, J., et al. (2018). Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17\/miR-224 and regulating p21, PTEN expression. Molecular Cancer, 17(1), 19.","journal-title":"Molecular Cancer"},{"issue":"9","key":"5162_CR29","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.15252\/embr.201643581","volume":"18","author":"Y Li","year":"2017","unstructured":"Li, Y., Zheng, F., Xiao, X., Xie, F., Tao, D., Huang, C., et al. (2017). CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Reports, 18(9), 1646\u20131659.","journal-title":"EMBO Reports"},{"issue":"3","key":"5162_CR30","doi-asserted-by":"publisher","first-page":"110.e11","DOI":"10.1016\/j.urolonc.2014.08.012","volume":"33","author":"B Liu","year":"2015","unstructured":"Liu, B., Miyake, H., Nishikawa, M., & Fujisawa, M. (2015). Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: Correlation with intravesical recurrence following transurethral resection. Urologic Oncology, 33(3), 110.e11\u20138.","journal-title":"Urologic Oncology"},{"issue":"6","key":"5162_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.4161\/cc.28128","volume":"13","author":"LZ Pan","year":"2014","unstructured":"Pan, L. Z., Ahn, D. G., Sharif, T., Clements, D., Gujar, S. A., & Lee, P. W. (2014). The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target. Cell Cycle, 13(6), 1041\u20131048.","journal-title":"Cell Cycle"},{"issue":"2","key":"5162_CR32","first-page":"1393","volume":"20","author":"K Chen","year":"2019","unstructured":"Chen, K., Ma, Y., Wu, S., Zhuang, Y., Liu, X., Lv, L., et al. (2019). Construction and analysis of a lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in diabetic cardiomyopathy. Molecular Medicine Reports, 20(2), 1393\u20131403.","journal-title":"Molecular Medicine Reports"},{"issue":"2","key":"5162_CR33","first-page":"578","volume":"45","author":"R Zhang","year":"2020","unstructured":"Zhang, R., Wang, J., Jia, E., Zhang, J., Liu, N., & Chi, C. (2020). lncRNA BCAR4 sponges miR-370-3p to promote bladder cancer progression via Wnt signaling. International Journal of Molecular Medicine, 45(2), 578\u2013588.","journal-title":"International Journal of Molecular Medicine"},{"key":"5162_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainres.2016.04.066","volume":"1644","author":"Z Peng","year":"2016","unstructured":"Peng, Z., Wu, T., Li, Y., Xu, Z., Zhang, S., Liu, B., et al. (2016). MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting \u03b2-catenin. Brain Research, 1644, 53\u201361.","journal-title":"Brain Research"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05162-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-024-05162-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05162-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T07:01:41Z","timestamp":1746860501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-024-05162-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["5162"],"URL":"https:\/\/doi.org\/10.1007\/s12010-024-05162-4","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"type":"print","value":"0273-2289"},{"type":"electronic","value":"1559-0291"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"24 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics and Scientific Committees of Central People\u2019s Hospital of Zhanjiang (No.2020ZJ0371) and performed in accordance with The Declaration of Helsinki. Written informed consent was obtained from all patients prior to the study start.And the Animal experiments were approved by Central People\u2019s Hospital of Zhanjiang Animal Experimental Ethics Committee (No.2020ZJ0822). All procedures complied with the National Institutes of Health Guide for the Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Written informed consent was obtained from each subject.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}